High-selective nerve stimulators treating neuropathic pain
Sensars Neuroprosthetics Sàrl
Incorporated
12.06.2014Headquarters
LausanneSupport
Sensars is a medtech start-up developing implantable neuroprosthetics for diabetic neuropathy complications such as diabetic foot ulcers, amputation and falls prevention and neuropathic pain treatment. Our flagship system, SENSY, restores natural foot sensation in patients with diabetes, sensory loss, or prosthetic limbs using neuromodulation and AI-driven gait analysis. By restoring sensation, SENSY prevents ulcers, amputations, falls, and chronic pain, improving patient survival and independence. Backed by FDA Breakthrough Device Designation, strong IP, and peer-reviewed clinical data, Sensars addresses a massive unmet need in diabetic foot care.
News
Sensars secures EUR 1.1 million in funding to advance revolutionary neuromodulation technology (venturelab.swiss)
Sensars secures investment and two grants worth EUR 1.1 million (startupticker.ch)
MassChallenge Switzerland 2022 Winners in the spotlight (startupticker.ch)
Twelve startups compete for the MassChallenge Switzerland award prize (startupticker.ch)
TOP 100 Satellite Event: 5 TOP 100 Swiss Startups pitch to Credit Suisse investors (TOP 100)
AMF Medical and Sensars receive FDA Breakthrough Device Designation (startupticker.ch)
European innovators under 35: MIT Technology Review selects SensArs’ founder Francesco Petrini (startupticker.ch)
SensArs coordinates a ?3 million grant to test its bionic prosthetics (startupticker.ch)
Sensars and ETH Zurich announce successful test of bionic prosthesis (startupticker.ch)
Sleepiz and nanoleq win ? 50,000 each (startupticker.ch)
Swiss start-ups receive financial support from Horizon 2020 SME instrument (startupticker.ch)
Swiss start-ups receive financial support from Horizon 2020 SME instrument (startupticker.ch)
Ten start-ups selected for the venture leaders Life Science program in Boston (startupticker.ch)
Ten start-ups selected for the venture leaders Life Science program in Boston (startupticker.ch)
SensArs Neuroprosthetics remporte 130'000 francs à l’issue de la finale Venture Kick (startupticker.ch)
Seven Swiss start-ups among the Imagine IF! Top 50 finalists (startupticker.ch)
Milestones news
CHF 600k; Added CFO; Expanded advisory board; Completed implantable product;
1.1M eur round of grants + convertible loan
Pilot clinical trial with SENSY
Support from SPECO
top 25 Venture
SensArs Incorporation